Drug Shortage Report for VITAMIN B12

Last updated on 2023-04-05 History
Report ID 186307
Drug Identification Number 00521515
Brand name VITAMIN B12
Common or Proper name VITAMIN B12
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VITAMIN B12
Strength(s) 1000MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 10ML
ATC code B03BA
ATC description VITAMIN B12 AND FOLIC ACID
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-06
Estimated end date 2023-03-31
Actual end date 2023-04-04
Shortage status Resolved
Updated date 2023-04-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-04-05 English Compare
v5 2023-04-04 French Compare
v4 2023-04-04 English Compare
v3 2023-03-07 English Compare
v2 2023-03-06 French Compare
v1 2023-03-06 English Compare

Showing 1 to 6 of 6